Finance, Insurance, And Real Estate / Security And Commodity Brokers, Dealers, Exchanges & Services
CME GROUP INC.
CME
$247.67
+$1.29 (+0.52%)
110 B
Market Cap (Large Cap)
93%
IV Rank
28.2%
Implied Volatility
Jul 21
Next Earnings
Insider Trades
8 buys
22 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| May 18, 2026 | Piell Hilda Harris | Sell | 5,753 | $1,752,536 | |
| May 18, 2026 | Piell Hilda Harris | Other | 5,753 | $1,752,536 | |
| May 15, 2026 | DUFFY TERRENCE A | Sell | 9,004 | $2,697,418 | |
| May 15, 2026 | DUFFY TERRENCE A | Sell | 25,996 | $7,750,447 | |
| May 15, 2026 | DUFFY TERRENCE A | Other | 9,004 | $2,697,418 | |
| May 15, 2026 | DUFFY TERRENCE A | Other | 25,996 | $7,750,447 | |
| Mar 26, 2026 | SHEPARD WILLIAM R | Buy | 62 | $18,438 | |
| Mar 26, 2026 | SHEPARD WILLIAM R | Buy | 1,408 | $418,711 | |
| Mar 26, 2026 | SHEPARD WILLIAM R | Other | 62 | $18,438 | |
| Mar 26, 2026 | SHEPARD WILLIAM R | Other | 1,408 | $418,711 |
Politician Trades in CME
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| Jan 09, 2026 | Gil Cisneros | D | Purchase | $1K-$15K |
| Jan 09, 2026 | Gil Cisneros | D | Purchase | $1K-$15K |
| Dec 18, 2025 | Julie Johnson | D | Sale | $1K-$15K |
| Nov 13, 2025 | Julie Johnson | D | Sale | $1K-$15K |
| Nov 03, 2025 | Ro Khanna | D | Purchase | $1K-$15K |
| Oct 07, 2025 | Ro Khanna | D | Purchase | $1K-$15K |
| Sep 23, 2025 | Val Hoyle | D | Sale | $1K-$15K |
| Sep 23, 2025 | Val Hoyle | D | Sale | $1K-$15K |
| Aug 26, 2025 | Ro Khanna | D | Sale | $1K-$15K |
| Aug 14, 2025 | Julie Johnson | D | Sale | $1K-$15K |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $3.40 | $3.36 | -1.2% | Miss |
| Dec 31, 2025 | Q4 2025 | $2.77 | $2.77 | 0.0% | Miss |
| Sep 30, 2025 | Q3 2025 | $2.66 | $2.68 | +0.8% | Beat |
| Jun 30, 2025 | Q2 2025 | $2.95 | $2.96 | +0.4% | Beat |
Track CME with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for CME and your entire portfolio.